The effect of adrenergic and cholinergic agents and their blockers upon ureteral activity.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001626:Bethanechol Compounds / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D008954:Models, Biological; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010477:Perfusion; D010646:Phentolamine / Q000494:pharmacology; D011312:Pressure; D011413:Propantheline / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D014513:Ureter / Q000187:drug effects* / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D001626:Bethanechol Compounds; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013565:Sympatholytics; D011413:Propantheline; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine